Elevation Oncology
(NASDAQ) ELEV
This security has been delisted. This page is retained for historical reference.
ELEV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowELEV Financials
Key Financial Metrics (TTM)
Gross Margin
37%
Operating Margin
-654%
Net Income Margin
-649%
Return on Equity
-46%
Return on Capital
-32%
Return on Assets
-30%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
-$24.00K
Operating Income
-$44.70M
EBITDA
-$43.22M
Operating Cash Flow
-$36.36M
Capital Expenditure
$0.00
Free Cash Flow
-$36.36M
Cash & ST Invst.
$93.18M
Total Debt
$31.13M
Elevation Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$5.00K
+50.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
34
N/A
Net Income
-$14.21M
-32.7%
EBITDA
-$14.22M
-44.2%
Quarterly Fundamentals
Total Cash
$80.66M
-22.5%
Total Debt
$31.25M
+1.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$31.25M
+1.4%
Short Term Debt
$0.00
N/A
Return on Assets
-29.98%
N/A
Return on Invested Capital
-31.87%
N/A
Free Cash Flow
-$12.71M
-32.8%
Operating Cash Flow
-$12.71M
-32.8%